Tenapanor Reduces Elevated Serum Phosphate in CKD
Adverse events limited to softened stool, modest increase in bowel movement freqeuncy
Chronic Kidney Disease
Positive Results Announced for First-in-Class Metabolic Acidosis Treatment
After 12 weeks, 59.2% of patients treated with the study drug saw an increased blood bicarbonate of ≥4mEq/L or achieved a level in the normal range (22 to 29mEq/L) vs 22.5% of patients in the placebo group (primary endpoint; P <.0001).
Treating HCV Infection May Prevent Development of Chronic Kidney Disease
Using several databases, the researchers examined the association of HCV infection with the incidence of CKD.
Smoking May Negate Renal Protective Effects of ACE Inhibitors
Cigarette smoking may blunt the renal protective effects of drugs taken by patients with early chronic kidney disease.
Small Decreases in Kidney Function Associated With CVD Risk
Even a slight decline in kidney function can potentially lead to heart damage, according to research published online in Hypertension.
